189 related articles for article (PubMed ID: 37543820)
1. Identification of novel immune-related biomarker and therapeutic drugs in Parkinson disease via integrated bioinformatics analysis.
Yang X; Wang Z
Medicine (Baltimore); 2023 Aug; 102(31):e34456. PubMed ID: 37543820
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
Chen X; Cao W; Zhuang Y; Chen S; Li X
Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
[TBL] [Abstract][Full Text] [Related]
3. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential biomarkers of gout through competitive endogenous RNA network analysis.
Li Y; Huang C; Yang Z; Wang L; Luo D; Qi L; Li Z; Huang Y
Eur J Pharm Sci; 2022 Jun; 173():106180. PubMed ID: 35378210
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.
Bao J; Chang W; Zhao Y
J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets.
Jin J; Liu Y; Tang Q; Yan X; Jiang M; Zhao X; Chen J; Jin C; Ou Q; Zhao J
Front Immunol; 2023; 14():1125183. PubMed ID: 37063926
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
9. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
10. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
[TBL] [Abstract][Full Text] [Related]
11. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
Cheng Q; Chen X; Wu H; Du Y
J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
14. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
Bai J; Pu X; Zhang Y; Dai E
Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes and therapeutic drugs in rheumatoid arthritis patients.
Wu B; He Y; Yang D; Liu RX
Clin Rheumatol; 2021 Aug; 40(8):3299-3309. PubMed ID: 33604823
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis for exploring potential biomarkers related to Parkinson's disease progression.
Huang Z; Song E; Chen Z; Yu P; Chen W; Lin H
BMC Med Genomics; 2024 May; 17(1):133. PubMed ID: 38760670
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of common molecular diagnostic biomarkers between chronic periodontitis and Parkinson's disease via bioinformatics analyses.
Zehui W; Mengting Z; Pengfei L; Yuanyin W; Jianguang X; Tao W
J Periodontal Res; 2023 Dec; 58(6):1212-1222. PubMed ID: 37664910
[TBL] [Abstract][Full Text] [Related]
18. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
Xing X; Xia Q; Gong B; Shen Z; Zhang Y
Front Genet; 2022; 13():855557. PubMed ID: 35368701
[No Abstract] [Full Text] [Related]
19. Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation
Chen C; Wu Y; Lu HL; Liu K; Qin X
PeerJ; 2022; 10():e13138. PubMed ID: 35313524
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]